Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for...
